Medifast (MED) Total Liabilities (2010 - 2026)

Medifast has reported Total Liabilities for 17 years, with the latest figure at $54.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 21.27% year-over-year to $54.4 million; the trailing twelve-month figure through Mar 2026 stood at $54.4 million (down 21.27% YoY), and the FY2025 full-year result was $49.1 million, down 33.81% from the prior year.
• Total Liabilities for Q1 2026 stood at $54.4 million, up from $49.1 million in the prior quarter.
• The five-year high for Total Liabilities was $211.1 million in Q2 2022, with the low at $49.1 million in Q4 2025.
• Historically, Total Liabilities has averaged $111.2 million across 5 years, with a median of $91.8 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 35.58% — and 2025, when it plunged 39.57%.
• Medifast's Total Liabilities stood at $161.2 million in 2022, then sank by 32.72% to $108.4 million in 2023, then plunged by 31.66% to $74.1 million in 2024, then sank by 33.81% to $49.1 million in 2025, then increased by 10.83% to $54.4 million in 2026.
• The last three Total Liabilities figures came in at $54.4 million (Q1 2026), $49.1 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.